Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Year range
1.
Hematol., Transfus. Cell Ther. (Impr.) ; 40(1): 5-11, Jan.-Mar. 2018. tab, ilus
Article in English | LILACS | ID: biblio-953798

ABSTRACT

Abstract Background: Pyruvate kinase deficiency is a hereditary disease that affects the glycolytic pathway of the red blood cell, causing nonspherocytic hemolytic anemia. The disease is transmitted as an autosomal recessive trait and shows a marked variability in clinical expression. This study reports on the molecular characterization of ten Brazilian pyruvate kinase-deficient patients and the genotype-phenotype correlations. Method: Sanger sequencing and in silico analysis were carried out to identify and characterize the genetic mutations. A non-affected group of Brazilian individuals were also screened for the most commonly reported variants (c.1456C>T and c.1529G>A). Results: Ten different variants were identified in the PKLR gene, of which three are reported here for the first time: p.Leu61Gln, p.Ala137Val and p.Ala428Thr. All the three missense variants involve conserved amino acids, providing a rationale for the observed enzyme deficiency. The allelic frequency of c.1456C>T was 0.1% and the 1529G>A variant was not found. Conclusion: This is the first comprehensive report on molecular characterization of pyruvate kinase deficiency from South America. The results allowed us to correlate the severity of the clinical phenotype with the identified variants.


Subject(s)
Humans , Male , Female , Pyruvate Kinase/deficiency , Erythrocytes , Anemia, Hemolytic , Mutation
2.
J. Soc. Bras. Fonoaudiol ; 24(4): 327-334, 2012. tab
Article in Portuguese | LILACS | ID: lil-660590

ABSTRACT

OBJETIVO: Estabelecer a frequência de mutações genéticas relacionadas à deficiência auditiva neurossensorial (DANS); verificar se há associação entre grau da DANS e presença de alteração genética e verificar se os Níveis Mínimos de Resposta (NMR) com próteses auditivas variam em função da alteração genética. MÉTODOS: Foram avaliadas 30 crianças, com idades entre 8 e 111 meses, usuárias de próteses auditivas. Os procedimentos de avaliação utilizados foram: audiometria tonal e resposta auditiva de estado estável (RAEE) em campo livre, com e sem as próteses auditivas e estudo genético da DANS. RESULTADOS: Foram diagnosticadas três mutações genéticas: 35delG, A1555G e A827G, sendo que as crianças com tais mutações apresentaram maior grau de DANS. Não houve diferença entre os padrões genéticos em relação ao grau de DANS, com exceção dos pacientes com mutação mitocondrial A827G, pois todos com essa mutação eram portadores de DANS de grau profundo. A diferença entre os NMR obtidos sem e com o uso da amplificação, considerando a presença de mutação e grau de DANS, foi maior nas crianças portadoras de DANS de grau moderado sem alteração genética, tanto na avaliação comportamental quanto na eletrofisiológica. CONCLUSÃO: As mutações genéticas foram encontradas em 36,7% da amostra, o que justifica a importância do rastreamento genético no processo de habilitação auditiva. Crianças com mutações genéticas apresentam o maior grau de DANS. Os diferentes padrões de mutações não determinam diretamente o grau da DANS. Os melhores limiares com o uso da amplificação foram encontrados nas crianças com DANS moderada, sem alteração genética.


PURPOSE: To establish the frequency of genetic mutations related to sensorineural hearing loss (SNHL); to verify if there is association between the degree of SNHL and the presence of genetic alteration; and to verify if the Minimal Response Levels (MRL) with hearing aids vary according to the genetic alteration. METHODS: Thirty hearing aids users with ages between 8 and 111 months were evaluated. The evaluation procedures used were: pure-tone audiometry; the auditory steady state response (ASSR) on sound field, with and without hearing aids; and genetic study of the hearing loss. RESULTS: Three genetic mutations were diagnosed: 35delG, A1555G and A827G, and the children with these mutations showed higher degree of SNHL. There was no difference between the genetic patterns regarding the degree of SNHL, except for patients with A827G mitochondrial mutation, because all subjects with this mutation had profound SNHL. The difference between the MRL obtained with and without amplification, considering the presence of mutation and the degree of SNHL, was higher in children with moderate SNHL without genetic alterations, both in behavioral and electrophysiological evaluations. CONCLUSION: Genetic mutations were found in 36.7% of the sample, justifying the importance of genetic tracking in the hearing habilitation process. Children with genetic mutations showed higher degrees of hearing loss. The different mutation patterns do not directly determine the degree of hearing loss. The best thresholds with amplification were found in children with moderate hearing loss without genetic alterations.


Subject(s)
Child , Child, Preschool , Female , Humans , Infant , Male , Hearing Aids , Hearing Loss, Sensorineural/genetics , Mutation/genetics , Audiometry, Pure-Tone , Auditory Threshold , Cross-Sectional Studies , Genotype , Hearing Loss, Sensorineural/rehabilitation , Phenotype , Severity of Illness Index
SELECTION OF CITATIONS
SEARCH DETAIL